Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Tina R. Juhl
Observed names:
T. Juhl,
T.R. Juhl,
Tina Juhl,
Tina R Juhl,
Tina Ragnholm Juhl
Institutions:
Copenhagen University Hospital,
Rigshospitalet
Observed institutions:
Novo Nordisk (Denmark),
Aarhus University,
Erasmus MC,
Copenhagen University Hospital,
Rigshospitalet,
Steno Diabetes Center Copenhagen
show all 6
OpenAlex ID:
A5020183352
Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial
2020
·
Nete Tofte
, Morten Lindhardt
, et al.
·
The Lancet Diabetes & Endocrinology
·
284
PDF
Beneficial impact of spironolactone in diabetic nephropathy
2005
·
Katrine Jordan Schjoedt
, Kasper Rossing
, et al.
·
Kidney International
·
254
Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy
2006
·
K.J. Schjoedt
, K. Rossing
, et al.
·
Kidney International
·
236
Renal Effects of Aliskiren Compared With and in Combination With Irbesartan in Patients With Type 2 Diabetes, Hypertension, and Albuminuria
2009
·
Frederik Persson
, Peter Rossing
, et al.
·
Diabetes Care
·
168
PDF
Time course of the antiproteinuric and antihypertensive effects of direct renin inhibition in type 2 diabetes
2008
·
F. Persson
, P. Rossing
, et al.
·
Kidney International
·
144
Paternal depression in the postnatal period assessed with traditional and male depression scales
2007
·
Svend Aage Madsen
, Tina Juhl
·
The Journal of Men s Health and Gender
·
142
Optimal dose of losartan for renoprotection in diabetic nephropathy
2002
·
S. Andersen
, Peter Rossing
, et al.
·
Nephrology Dialysis Transplantation
·
70
Long-Term Renoprotective Effects of Losartan in Diabetic Nephropathy
2003
·
Steen Andersen
, Lise Tarnow
, et al.
·
Diabetes Care
·
60
PDF
Renoprotective effects of losartan in diabetic nephropathy: Interaction with ACE insertion/deletion genotype?
2002
·
Steen Andersen
, Lise Tarnow
, et al.
·
Kidney International
·
38
Optimal antiproteinuric dose of aliskiren in type 2 diabetes mellitus: a randomised crossover trial
2010
·
F. Persson
, P. Rossing
, et al.
·
Diabetologia
·
35
PDF
Time course of the antiproteinuric and antihypertensive effect of losartan in diabetic nephropathy
2003
·
S. Andersen
, Peter Jacobsen
, et al.
·
Nephrology Dialysis Transplantation
·
29
Długoterminowy efekt nefroprotekcyjny losartanu w nefropatii cukrzycowej. Interakcja z genotypem delecji/insercji ACE?
2003
·
Steen Andersen
, Lise Tarnow
, et al.
·
Clinical Diabetology
Show more works
View as search
Works count:
13
Citation count:
1,460
H-index:
11
I10-index:
11
Year
Topic
Type